Regeneron Pharmaceuticals
REGN
#363
Rank
โ‚น6.544 T
Marketcap
โ‚น62,427
Share price
4.73%
Change (1 day)
35.90%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น458.22 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.91 Billion. In 2025 the company made an earning of โ‚น499.08 Billion, an increase over its 2024 earnings that were of โ‚น456.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น458.22 B-8.19%
2025 โ‚น499.08 B9.43%
2024 โ‚น456.07 B13.83%
2023 โ‚น400.67 B-13.57%
2022 โ‚น463.60 B-47.9%
2021 โ‚น889.82 B144.75%
2020 โ‚น363.56 B56.86%
2019 โ‚น231.77 B-4.87%
2018 โ‚น243.64 B22.86%
2017 โ‚น198.32 B56.3%
2016 โ‚น126.88 B8.55%
2015 โ‚น116.89 B54.53%
2014 โ‚น75.64 B11.14%
2013 โ‚น68.06 B72.13%
2012 โ‚น39.54 B-285.93%
2011 -โ‚น21.27 Billion121.73%
2010 -โ‚น9.6 Billion37.18%
2009 -โ‚น7 Billion-14.6%
2008 -โ‚น8.19 Billion-25.02%
2007 -โ‚น10.93 Billion6.32%
2006 -โ‚น10.28 Billion-186.52%
2005 โ‚น11.87 B2103.7%
2004 โ‚น0.53 B-105.66%
2003 -โ‚น9.53 Billion-18.18%
2002 -โ‚น11.64 Billion42.33%
2001 -โ‚น8.18 Billion129.35%
2000 -โ‚น3.57 Billion51.87%
1999 -โ‚น2.35 Billion92.19%
1998 -โ‚น1.23 Billion66.23%
1997 -โ‚น0.74 Billion-55.49%
1996 -โ‚น1.66 Billion103.53%
1995 -โ‚น0.82 Billion-70.89%
1994 -โ‚น2.79 Billion-26.08%
1993 -โ‚น3.77 Billion114.67%
1992 -โ‚น1.76 Billion196.77%
1991 -โ‚น0.6 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.478 T 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.506 T 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น867.03 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น730.73 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น154.85 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.97 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA